全文获取类型
收费全文 | 279156篇 |
免费 | 13120篇 |
国内免费 | 7094篇 |
专业分类
耳鼻咽喉 | 3421篇 |
儿科学 | 8576篇 |
妇产科学 | 6666篇 |
基础医学 | 33878篇 |
口腔科学 | 7249篇 |
临床医学 | 26721篇 |
内科学 | 46215篇 |
皮肤病学 | 5154篇 |
神经病学 | 15352篇 |
特种医学 | 13314篇 |
外国民族医学 | 145篇 |
外科学 | 36473篇 |
综合类 | 19275篇 |
现状与发展 | 31篇 |
一般理论 | 3篇 |
预防医学 | 23131篇 |
眼科学 | 6464篇 |
药学 | 23402篇 |
108篇 | |
中国医学 | 6677篇 |
肿瘤学 | 17115篇 |
出版年
2023年 | 1602篇 |
2022年 | 3939篇 |
2021年 | 4888篇 |
2020年 | 3877篇 |
2019年 | 3050篇 |
2018年 | 6456篇 |
2017年 | 6887篇 |
2016年 | 5817篇 |
2015年 | 9087篇 |
2014年 | 9403篇 |
2013年 | 8103篇 |
2012年 | 16859篇 |
2011年 | 12119篇 |
2010年 | 7369篇 |
2009年 | 8244篇 |
2008年 | 7036篇 |
2007年 | 7479篇 |
2006年 | 7431篇 |
2005年 | 15020篇 |
2004年 | 15340篇 |
2003年 | 10746篇 |
2002年 | 5536篇 |
2001年 | 6217篇 |
2000年 | 3349篇 |
1999年 | 7408篇 |
1998年 | 1419篇 |
1992年 | 7230篇 |
1991年 | 7450篇 |
1990年 | 7616篇 |
1989年 | 7165篇 |
1988年 | 6677篇 |
1987年 | 6403篇 |
1986年 | 6076篇 |
1985年 | 5330篇 |
1984年 | 3631篇 |
1983年 | 2951篇 |
1979年 | 3846篇 |
1978年 | 2370篇 |
1977年 | 1783篇 |
1976年 | 1560篇 |
1975年 | 2476篇 |
1974年 | 3106篇 |
1973年 | 2741篇 |
1972年 | 2759篇 |
1971年 | 2744篇 |
1970年 | 2559篇 |
1969年 | 2466篇 |
1968年 | 2239篇 |
1967年 | 2164篇 |
1966年 | 1901篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
目的探讨鼓膜穿刺加压灌注疗法治疗分泌性中耳炎的临床疗效。方法选择确诊为分泌性中耳炎患者88例为研究对象,所有患者采用中耳鼓膜穿刺鼓室灌注加压治疗。比较不同性质分泌物患者的临床疗效及治疗前后患者鼓室导抗图变化。结果胶冻状患者治疗时间最长,浆液性患者治疗时间最短,三组治疗时间比较差异有统计学意义(P<0.01)。浆液性总有效率94.0%,黏液性总有效率86.8%,胶冻状总有效率75.0%,三组比较有显著差异(P<0.05)。治疗前鼓室导图主要是B型,治疗后主要是A型,治疗前后比较差异有统计学意义(P<0.01)。结论鼓膜穿刺加压灌注治疗分泌性中耳炎具有较好的临床疗效。 相似文献
22.
23.
Platelet function has been described by many laboratory assays, and PL-11 is a new point-of-care platelet function analyzer based on platelet count drop method, which counts platelet before and after the addition of agonists in the citrated whole blood samples. The present study sought to compare PL-11 with other three major more established assays, light transmission aggregometry (LTA), VerifyNow? aspirin system and thromboelastography (TEG), for monitoring the short-term aspirin responses in healthy individuals. Ten healthy young men took 100?mg/d aspirin for 3-day treatment. Platelet function was measured via PL-11, LTA, VerifyNow and TEG, respectively. The blood samples were collected at baseline, 2 hour, 1 day during the aspirin treatment and 1 day, 5?±?1 days, 8?±?1 days after the aspirin withdrawal. Moreover, 90 additional healthy subjects were recruited to establish a reference range for PL-11. Platelet function of healthy subjects decreased significantly 2 hours after 100?mg/d aspirin intake and began to recover during 4–6 days after the aspirin withdrawal. Correlations between methods were PL-11 vs. LTA (r?=?0.614, p?<?0.01); PL-11 vs. VerifyNow (r?=?0.829, p?<?0.01); PL-11 vs. TEG (r?=?0.697, p?<?0.001). There was no significant bias between PL-11 and LTA at baseline (bias?=?1.94%, p?=?0.804) using Bland-Altman analysis, while the data of PL-11 were significantly higher than LTA (bias?=?24.02%, p?<?0.001) during the aspirin therapy. The reference range for PL-11 in healthy young individuals was from 66.8 to 90.5% (95%CI). When aspirin low-responsiveness was defined as LTA?>?20%, the cut-off values for each method were, respectively: PL-11?>?50%, VerifyNow?>?533 ARU, TEG?>?60.2%. The results of different platelet function assays were uninterchangeable for monitoring aspirin response and correlations among them were also varied. Correlations among PL-11 and other three major assays suggested the ability of PL-11 to assess the treatment effects of aspirin. But a large cohort study is needed to confirm the cut-off value of aspirin response detected by PL-11. 相似文献
24.
25.
目的 通过对公开发表在网络和数据库的有关中医药治疗2019新型冠状病毒肺炎(corona virus disease 2019,COVID-19)的文献进行方、药、证的可视化分析,客观全面的对COVID-19的中医药治疗进行探讨,为现代中医临床诊疗提供参考。方法 本文选用运用文献计量学方法和VOSviewer可视化软件对纳入文献中的用药情况进行数据拆分、整理和分析。结果 本研究高质量数据的主要期刊来源是核心期刊《中医杂志》;新冠临床用方以解表清热剂、开窍补益剂、辟秽祛湿剂为主;临床用药以解表药、清热解毒药、化湿祛痰药以及补益药为主;临床治病思路以六经辨证、三焦辨证和卫气营血辨证理论为指导;临床常见证型为湿、热、寒、毒相关证型;重视新冠前期预防以及后期恢复调养;治疗过程用药考究,注重养阴与祛邪并进。结论 新冠的中医临床诊治考病全面,并注重养阴与祛邪并进,可为官方制定治疗方案提供参考。 相似文献
26.
27.
Attachment is a behavioral and physiological system, which enables individual’s dynamic adaptation to its environment. Attachment develops in close interaction between an infant and his/her mother, plays an important role in the development of the infant’s brain, and influences the quality of interpersonal relationships throughout life.Security of attachment is believed to influence individual response to stress, exposing insecurely organized individuals to deregulated autonomic nervous system and exaggerated hypothalamic-pituitary-adrenal activity, which, in turn, produces increased and prolonged exposure to stress-hormones. Such stress responses may have considerable implications for the development of diverse health-risk conditions, such as insulin resistance and hyperlipidemia, shown by numerous studies.Although the mechanisms are not yet fully understood, there is compelling evidence highlighting the role of psychological stress in the development of type 1 diabetes (T1D). One of the possible contributing factors for the development of T1D may be the influence of attachment security on individual stress reactivity. Thus, the suggestion is that insecurely attached individuals are more prone to experience increased and prolonged influence of stress hormones and other mechanisms causing pancreatic beta-cell destruction.The present paper opens with a short overview of the field of attachment in children, the principal attachment classifications and their historic development, describes the influence of attachment security on individual stress-reactivity and the role of the latter in the development of T1D. Following is a review of recent literature on the attachment in patients with T1D with a conclusion of a proposed role of attachment organization in the etiology of T1D. 相似文献
28.
Torbj?rn Karlsson 《Upsala journal of medical sciences》2015,120(4):257-262
Background. Haemophagocytic lymphohistiocytosis (HLH) is a rare clinical syndrome characterized by fever, hepatosplenomegaly, cytopenia, and progressive multiple-organ failure. HLH in adults is often secondary to autoimmune diseases, cancer, or infections in contrast to familial HLH. Treatment of secondary HLH is directed against the triggering disease in addition to immunosuppressive therapy, the latter commonly according to the HLH-2004 protocol.Methods. We conducted a retrospective study to identify triggering diseases, disease-specific and immunosuppressive therapy administered, and prognosis in adult patients with secondary HLH. Patient data were collected from October 2010 to January 2015.Results. Ten adult patients with secondary HLH were identified. Seven were men, and the median age at diagnosis was 62 years. Five cases were triggered by malignant disease and five by infection. The median patient fulfilled five of the eight HLH-2004 diagnostic criteria. All patients fulfilled the criteria fever, cytopenia, and ferritin >500 µg/L. Median time from hospital admission to HLH diagnosis was 20 days. Four patients received immunosuppressive therapy according to the HLH-2004 protocol. The prognosis was dismal, especially for the patients with malignancy-associated HLH, of whom all died.Conclusion. HLH should be suspected in patients who present with fever, cytopenia, and ferritin >500 µg/L. Secondary HLH has a dismal prognosis. None of the patients with HLH triggered by malignancy survived. Achieving remission of the triggering disease seems to be important for a favourable outcome as, in all surviving patients, the haemophagocytic syndrome resolved after remission of the underlying infection. 相似文献
29.
30.